BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Study Results Abstracts From Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium

  February 13, 2025

   · 

  5 min read
• Press Releases

  Aardvark Therapeutics Announces Pricing of Initial Public Offering

  February 13, 2025

   · 

  4 min read
• Press Releases

  atai Life Sciences Announces Pricing of Public Offering of Common Shares

  February 13, 2025

   · 

  3 min read
• Press Releases

  Ipsen delivers solid results in 2024, driven by strong performance across all therapeutic areas, and provides guidance for 2025

  February 13, 2025

   · 

  8 min read
• Press Releases

  iLeadBMS Announces Orphan Drug Designation Granted by the FDA for IL21120033 (CXCR7 Agonist) for Idiopathic Pulmonary Fibrosis

  February 13, 2025

   · 

  1 min read
• Press Releases

  Santhera Announces Agreement with German GKV-SV on Reimbursement Amount for AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy in Germany

  February 13, 2025

   · 

  5 min read
• Press Releases

  Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

  February 13, 2025

   · 

  6 min read
• Press Releases

  DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

  February 13, 2025

   · 

  1 min read
• Press Releases

  Vistin Pharma ASA: Fourth quarter and preliminary 2024 financial results

  February 13, 2025

   · 

  1 min read
• Press Releases

  PulseSight Therapeutics Announces First Close of its Series A Financing to Fund Clinical Development of PST-611 in dry AMD

  February 13, 2025

   · 

  4 min read